Logo Presseportal

full version of Presseportal
 Tech 
 Police 



18.07.2024 - 11:05
Waiblingen, Germany (ots) - - The Vivalytic test is the first test to specifically detect 3 of the most important gastroenteristis pathogens: Clostridioides difficile, norovirus, and rotavirus. - Clostridioides difficile infection rates are on the ...To the press release of Bosch Healthcare Solutions GmbH
One image:
Preview  HiResDownload


16.05.2024 - 10:05
Waiblingen (ots) - - Vivalytic test detects Candida auris in under an hour at the point of care, making it the world’s first test suitable for screenings. - Candida auris infection rates are on the rise in Germany and can cause severe infections, ...To the press release of Bosch Healthcare Solutions GmbH


18.04.2024 - 10:15
Darmstadt, Gerlingen, and Waiblingen, Germany (ots) - Plans to use innovative Bosch BioMEMS technology in PCR tests for multiresistant bacteria - Bosch and R-Biopharm are jointly investing 150 million euros in the development of new PCR tests and in ...To the press release of Bosch Healthcare Solutions GmbH


10.04.2024 - 14:05
Waiblingen (ots) - - Bosch and Randox Laboratories Ltd. enter partnership for Vivalytic analysis platform to jointly invest around 150 million euros. - First test to feature novel BioMEMS technology will be a highly multiplexing sepsis IVD grade ...To the press release of Bosch Healthcare Solutions GmbH


27.09.2022 - 09:35
Waiblingen (ots) - - As a real-time PCR rapid test at the point of care (POC), the Vivalytic test MRSA/SA can detect two of the most important pathogens associated with hospital-acquired infections. - Differentiation as to whether the bacterial ...To the press release of Bosch Healthcare Solutions GmbH
One image:
Preview  HiResDownload